NCT05467813 Mirror Therapy Preceding Augmented Reality in Stroke Rehabilitation
| NCT ID | NCT05467813 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Stroke Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-07-23 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2022-07-23 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This proposed research is in line with the National Health Research Institutes (NHRI) Innovative Research Grant priority to address innovative treatment strategies for neurological disorders that are in desperate need of scientific scrutiny. Stroke is one of the major medical conditions that leads to long-term disability and causes a heavy health care and financial burden. To meet multiple needs of patients with stroke, hybrid interventions that combine different approaches and practices in different settings are needed based on the complexity of stroke. Our previous research funded by the NHRI has been published and translated to stroke rehabilitation. Extending our previous research, the investigators will study the benefits of novel rehabilitation regimens of mirror therapy preceding augmented reality as well as the effects of practice setting (i.e., clinic- vs. home-based settings). In line with the current trend for the development of mirror therapy, mirror therapy will be implemented based on the bilateral and unilateral approach. Augmented reality will be implemented as a means of exergaming with real-time feedback to motivate the patients with stroke for active participation. In addition, telehealth techniques will be used to monitor home practice. This research is innovative in the use of telehealth techniques that will meet the call for therapy outside of the clinical settings in the era of COVID-19 pandemic.
Eligibility Criteria
Inclusion Criteria: 1. a first-ever unilateral stroke ≥3 months 2. age between 20 and 80 years 3. baseline FMA-UE \>10 4. no severe spasticity in any joints of the affected arm MAS \< 3) 5. ability to follow the instructions of the evaluator and therapists (Mini-Mental State Examination Score ≥22) 6. ability to stand in a step-standing position for at least 30 seconds 7. ability to walk a minimum of 10 meters with or without a device 8. no severe vision impairments and other major neurologic diseases 9. ability to take part in a rehabilitation intervention program for 9 weeks 10. not participating in other studies over the study period and willingness to provide informed written consent. Exclusion Criteria: 1. acute inflammation 2. serious medical problems or poor physical conditions that might be detrimental to study participation
Contact & Investigator
Keh-Chung Lin, Sc.D
PRINCIPAL INVESTIGATOR
National Taiwan University
Frequently Asked Questions
Who can join the NCT05467813 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Stroke Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05467813 currently recruiting?
Yes, NCT05467813 is actively recruiting participants. Contact the research team at kehchunglin@ntu.edu.tw for enrollment information.
Where is the NCT05467813 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan, Taichung, Taiwan, Taipei, Taiwan, Taipei, Taiwan and 1 additional location.
Who is sponsoring the NCT05467813 clinical trial?
NCT05467813 is sponsored by National Taiwan University Hospital. The principal investigator is Keh-Chung Lin, Sc.D at National Taiwan University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.